U.S., March 19 -- An application to own the trademark for 'REJUVENRX' has been filed on Jan. 04, 2021.
Owner(s):
RejuvenRx Inc.; 2950 chemin Polytechnique, , CANADA
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory muscle diseases and disorders, and central nervous system diseases and disorders, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Development of pharmaceutical preparations and medicines
Class(es): 100, 101
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-03-18&serialNumber=90446720
Disclaimer: Curated by HT Syndication....